• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
ExonHit Therapeutics SA Product Pipeline Analysis Product Image

ExonHit Therapeutics SA Product Pipeline Analysis

  • ID: 605479
  • January 2009
  • 19 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Aniara Corporation
  • Texas Biosystems, Inc.
  • Trace Genetics, Inc.
  • MORE

ExonHit Therapeutics SA Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.

Reasons to buy

- A single READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aniara Corporation
  • Texas Biosystems, Inc.
  • Trace Genetics, Inc.
  • MORE

1 2
1.1 List Of Tables 4
1.2 List of Figures 5
2 Company Overview 6
2.1 Key Information 6
2.2 Industry Outlook - In Vitro Diagnostics 6
3 ExonHit Therapeutics SA Pipeline Products 7
3.1 ExonHit Therapeutics SA Product Pipeline Analysis 7
3.1.1 ExonHit Therapeutics SA Pipeline Products By Equipment Type 7
3.1.2 ExonHit Therapeutics SA Pipeline Products By Development Stage 9
3.1.3 ExonHit Therapeutics SA Pipeline Products By Therapy Area 9
3.1.4 ExonHit Therapeutics SA Pipeline Products By News Summary 10
3.2 EHT Dx 31 11
3.2.1 Product Status 11
3.2.2 Product Description 11
3.3 EHT Dx 11 11
3.3.1 Product Status 11
3.3.2 Product Description 12
3.4 EHT Dx 12 12
3.4.1 Product Status 12
3.4.2 Product Description 12
3.5 EHT Dx13 13
3.5.1 Product Status 13
3.5.2 Product Description 13
3.6 EHT Dx 21 13
3.6.1 Product Status 13
3.6.2 Product Description 14
3.6.3 Product Milestone 14
3.6.4 Product Patent Details 14
4 Recent Developments 16
4.1 Product Approvals 16
4.1.1 Dec 20, 2007: Exonhit Gets Regulatory Approval To Initiate A Phase 2 Clinical Trial For EHT 0202 In Alzheimers Disease 16
5 Appendix 17
5.1 Methodology 17
5.1.1 Coverage 17
5.1.2 Secondary Research 18
5.1.3 Primary Research 18
5.1.4 Expert Panel Validation 19
5.2 Contact Us 19
5.3 About us19
5.4 Disclaimer 19

Executive Summary

1.2 List of Figures
Figure 1: ExonHit Therapeutics SA Pipeline Products By Equipment Type 7
Figure 2: ExonHit Therapeutics SA Pipeline Products By Equipment Type 8
Figure 3: ExonHit Therapeutics SA Pipeline Products By Development Stage 9
Figure 4: ExonHit Therapeutics SA Pipeline Products By News Summary 10
Figure 5: Global Markets Direct Methodology 17

Note: Product cover images may vary from those shown

The following companies are the major competitors of ExonHit Therapeutics SA:
Full Moon BioSystems, Inc.
Texas Biosystems, Inc.
Aniara Corporation
Trace Genetics, Inc.
Iverson Genetic Diagnostics, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos